RANBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Here, we reported the reduction of p(ser112)-BAD and cytoplasm ERK1/2 in RanBP3-silenced CML cells, suggesting that the RanBP3 silencing induced apoptosis may be related to MAPK signaling.